Pentaglobin
- Generic Name
- Pentaglobin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 97794-27-9
- Unique Ingredient Identifier
- -
- Background
Pentaglobin, also known as IgM-enriched immunoglobulin, falls under a group of polyclonal immunoglobulin preparations. It is comprised of immunoglobulin G (IgG) and immunoglobulin A (IgA) while also being enriched by immunoglobulin M (IgM).
- Associated Conditions
- -
- Associated Therapies
- -
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 500
- Registration Number
- NCT04351724
- Locations
- 🇦🇹
Medical University of Innsbruck, Innsbruck, Tirol, Austria
🇦🇹Wilhelminenspital, Vienna, Austria
🇦🇹SMZ Ost Donauspital, Vienna, Austria
Pentaglobin in CRE and PA Neutropenic Infections
- First Posted Date
- 2018-04-11
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Target Recruit Count
- 120
- Registration Number
- NCT03494959
- Locations
- 🇮🇹
Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza, Foggia, Italy
🇮🇹Cattedra di Ematologia - Policlinico, Roma, Italy
🇮🇹Ospedale Moscati, Taranto, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath